Cubist Systematic Strategies’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,900
Closed -$203K 2799
2024
Q4
$203K Buy
+2,900
New +$241K ﹤0.01% 2564
2024
Q3
Sell
-8,800
Closed -$1.25M 2920
2024
Q2
$1.25M Buy
+8,800
New +$1.01M 0.01% 1612
2024
Q1
Sell
-6,700
Closed -$869K 3636
2023
Q4
$869K Sell
6,700
-10,300
-61% -$1.42M 0.01% 2151
2023
Q3
$2.77M Sell
17,000
-10,800
-39% -$1.9M 0.02% 1133
2023
Q2
$5.1M Buy
27,800
+2,100
+8% +$302K 0.03% 837
2023
Q1
$3.42M Buy
+25,700
New +$3.02M 0.02% 1236

Other funds holding ACLS

Cubist Systematic Strategies's ACLS Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Axcelis (ACLS) in Q2 2024, closing a stake of 64,445 shares — an estimated $7.43M sold.

Cubist Systematic Strategies first reported a position in ACLS in Q1 2015 and held it in 24 quarters. The position peaked at $24.7M in Q4 2023. 392 funds tracked by Wall St. Rank hold ACLS as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Axcelis position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 64,445 Axcelis shares in Q2 2024, an estimated $7.43M.
  • Cubist Systematic Strategies first reported a position in Axcelis in Q1 2015 and held it in 24 quarters.
  • Cubist Systematic Strategies's Axcelis position peaked at $24.7M in Q4 2023.
  • 392 funds tracked by Wall St. Rank held Axcelis as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.